Newcastle University has developed a high-throughput encapsulated nanodroplet screening method (ENaCt) to accelerate the discovery of multi-component co-crystals. By using liquid-handling robotics to screen thousands of experiments with minimal sample requirements, this research-based approach enables the rapid identification and structural characterization of binary, ternary, and quaternary co-crystals, offering a significant advancement for pharmaceutical research and drug development.
High-throughput encapsulated nanodroplet screening for multi-component co-crystals is a research-based methodology developed by Newcastle University to accelerate the discovery of co-crystals. Co-crystals, which consist of two or more chemically inequivalent molecules, are vital in pharmaceutical development for improving the stability and bioavailability of active pharmaceutical ingredients. This method, known as Encapsulated Nanodroplet Crystallisation (ENaCt), addresses the resource-intensive nature of traditional co-crystal screening by enabling the rapid, parallel exploration of complex experimental landscapes using minimal sample quantities.
The technology is at TRL 6. It has been validated through extensive laboratory research and published studies, including the successful discovery of numerous novel binary, ternary, and quaternary co-crystal structures. The methodology has been demonstrated in collaboration with industry partners, such as AstraZeneca, to show its practical utility in accelerating drug development pipelines. While it is a proven research tool used in academic and collaborative settings, it is described as a developed method rather than a commercial product...
Newcastle University is a comprehensive public research university in Newcastle upon Tyne, with broad academic and translational activity. Its city‑centre Newcastle Helix innovation district—developed with Newcastle City Council and Legal & General—co‑locates researchers with companies and hosts national innovation centres to enable fast collaboration. Deep integration with Newcastle upon Tyne Hospitals NHS Foundation Trust, supported by a joint research office, enables streamlined study setup, access to clinical populations, and end‑to‑end clinical translation. Research is backed by competitive funding from UKRI councils, the National Institute for Health and Care Research, major charities, the European Union, and industry. A dedicated technology transfer office supports IP, licensing, spinouts, and knowledge‑transfer partnerships.